#texas-health-services

#texas-health-services

"Camp Mystic is carefully reviewing the notice from DSHS and we are working closely with DSHS through the appropriate process to address the areas outlined. Our priority remains the safety and well-being of our campers."

My mother tells me not to be afraid, that 'what [you] fear will come upon [you].' She is quoting from the book of Job, the Bible's most famous theodicy.

Most people leave doctor visits with prescriptions, but still feel unsure—instructions make sense, but no one asks about their life. In contrast, when a provider knows your name, remembers your story, and explains care in a way that fits you, the experience feels different—and that difference matters.

Congress has kept key drug assistance funding at $900.3 million annually since 2014. New enrollments for state programs jumped 30% from 2022 to 2024, in part because states cut off pandemic-era Medicaid assistance. As of January, at least 18 states have pulled back their Ryan White AIDS Drug Assistance Programs, known as ADAPs, in some way.

Because of budget cuts, the Los Angeles County Department of Public Health has ended clinical services at seven of its public health clinic sites. As of Feb. 27, the county is no longer providing services such as vaccinations, sexually transmitted infection testing and treatment, or tuberculosis diagnosis and specialty TB care at the affected locations, according to county officials and a department fact sheet.

In light of the systemic dismantling of America's public health agencies, these moves essentially create a shadow infrastructure to maintain some of what is being lost. While this is a promising development, it does nothing to stop a troubling trend that has been emerging for some time: The country is quickly becoming fragmented along partisan lines when it comes to public health.

The 340B program allows hospitals to buy outpatient drugs at steep discounts, with the purported purpose of helping them fund care for low-income and uninsured patients. The now-axed rebate model would have invited drugmakers to participate voluntarily in a rebate-based discount system. Basically, instead of the provider receiving a discount upfront at purchase, the 340B discount would be applied after purchase via rebate - and subject to tedious data submission requirements.